Sbi Securities Co., Ltd. Lava Therapeutics Nv Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 300 shares of LVTX stock, worth $288. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$288% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LVTX
# of Institutions
28Shares Held
3.61MCall Options Held
32.9KPut Options Held
500-
Redmile Group, LLC San Francisco, CA2.07MShares$1.99 Million0.23% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$740,9990.53% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3146KShares$140,5980.04% of portfolio
-
Two Sigma Investments, LP New York, NY103KShares$98,6550.0% of portfolio
-
Pathway Financial Advisors LLC103KShares$98,4000.02% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $24.8M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...